Samsung SGH-V206MSAAWS - Manual (Page 75)

Appendix C: Consumer Update on Wireless Phones
146
Support needed research into possible biological
effects of RF of the type emitted by wireless phones;
Design wireless phones in a way that minimizes any
RF exposure to the user that is not necessary for
device function; and
Cooperate in providing users of wireless phones with
the best possible information on possible effects of
wireless phone use on human health
FDA belongs to an interagency working group of the
federal agencies that have responsibility for different
aspects of RF safety to ensure coordinated efforts at
the federal level. The following agencies belong to
this working group:
National Institute for Occupational Safety and Health
Environmental Protection Agency
Federal Communications Commission
Occupational Safety and Health Administration
National Telecommunications and Information
Administration
The National Institutes of Health participates in some
interagency working group activities, as well.
FDA shares regulatory responsibilities for wireless
phones with the Federal Communications
Commission (FCC). All phones that are sold in the
United States must comply with FCC safety
guidelines that limit RF exposure. FCC relies on FDA
and other health agencies for safety questions about
wireless phones.
FCC also regulates the base stations that the wireless
phone networks rely upon. While these base stations
operate at higher power than do the wireless phones
themselves, the RF exposures that people get from
these base stations are typically thousands of times
lower than those they can get from wireless phones.
Base stations are thus not the primary subject of the
safety questions discussed in this document.
Appendix C: Consumer Update on Wireless Phones
147
4. What is FDA doing to find out more about the
possible health effects of wireless phone RF?
FDA is working with the U.S. National Toxicology
Program and with groups of investigators around the
world to ensure that high priority animal studies are
conducted to address important questions about the
effects of exposure to radio frequency energy (RF).
FDA has been a leading participant in the World
Health Organization International Electromagnetic
Fields (EMF) Project since its inception in 1996. An
influential result of this work has been the
development of a detailed agenda of research needs
that has driven the establishment of new research
programs around the world. The Project has also
helped develop a series of public information
documents on EMF issues.
FDA and the Cellular Telecommunications & Internet
Association (CTIA) have a formal Cooperative
Research and Development Agreement (CRADA) to
do research on wireless phone safety. FDA provides
the scientific oversight, obtaining input from experts
in government, industry, and academic
organizations. CTIA-funded research is conducted
through contracts to independent investigators. The
initial research will include both laboratory studies
and studies of wireless phone users. The CRADA will
also include a broad assessment of additional
research needs in the context of the latest research
developments around the world.